Thomas M. Lietman MD
Professor and Director, Francis I Proctor Foundation, UCSF School of Medicine
Join to View Full Profile
95 Kirkham StF.I. Proctor FoundationSan Francisco, CA 94143
Phone+1 415-476-1442
Fax+1 415-476-0527
Dr. Lietman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 1991 - 1994
MedStar Health Georgetown University (Baltimore)Internship, Internal Medicine, 1990 - 1991
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Yale CollegeBA, 1980 - 1984
Certifications & Licensure
CA State Medical License 1994 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Trachoma Elimination Follow-up Start of enrollment: 2003 Mar 01
- Steroids for Corneal Ulcers Trial Start of enrollment: 2006 Sep 01
- Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Seasonality of underweight among infants 1-11 months old in Niger: an exploratory analysis of data from a cluster-randomised trial.Brittany Peterson, Ahmed Mamane Arzika, Ramatou Maliki, Amza Abdou, Bawa Aichatou
BMJ Global Health. 2025-03-28 - Mass distribution of azithromycin and child mortality among underweight infants in rural Niger: a subgroup analysis of the AVENIR cluster-randomised trial.Brittany Peterson, Ahmed Arzika, Ramatou Maliki, Amza Abdou, Bawa Aichatou
BMJ Open. 2025-03-27 - Association of Weather Variables With Pathogens Contributing to Conjunctivitis Worldwide.Daisy Yan, N Venkatesh Prajna, Prajna Lalitha, Wiwan Sansanayudh, Vannarut Satitpitakul
Clinical Infectious Diseases. 2025-03-17
Journal Articles
- Mass Azithromycin Distribution for Hyperendemic Trachoma Following a Cluster-Randomized Trial: A Continuation Study of Randomly Reassigned Subclusters (TANA II)Jeremy D Keenan, Thomas M Lietman, PLoS One
- F Effect of Antibiotics on Short-Term Growth Among Children in Burkina Faso: A Randomized TrialThomas M Lietman, Jeremy D Keenan, The American Journal of Tropical Medicine and Hygiene
- Anthropometry and Malaria Among Children in Niger: A Cross-Sectional StudyThomas M Lietman, Bruce D Gaynor, The American Journal of Tropical Medicine and Hygiene
- Join now to see all
Press Mentions
Giving an Antibiotic to All Children Under 5 in Africa Saves LivesAugust 21st, 2024- Common Antibiotic No More Effective Than Placebo in Preventing COVID-19 Symptoms Among Non-Hospitalized: Outpatient Study Found Limited Effect of Azithromycin on Progression of DiseaseJuly 18th, 2021
- Study Suggests Mass Azithromycin May Promote Resistance to Other AntibioticsNovember 13th, 2020
- Join now to see all
Grant Support
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Résistance Evaluée contre la Vie des Enfants au Niger-Implementation et Recherche (REVENIR). Community antimicrobial resistance after azithromycin distribution: selection, spillover, co-selectionUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2028
- Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
- Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
- Forecasting Trachoma ControlUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2016–2028
- Azithromycin Reduction to Reach Elimination of TrachomaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- UCSF-Proctor Clinician Vision Scholars K12 ProgramUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
- Steroids and Cross-linking for Ulcer Treatment (SCUT II)UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025
- Kebele Elimination of Trachoma for Ocular HealthUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2017–2025
- Tana IINational Eye Institute2010–2011
- Myocotic Ulcer Treatment TrialNational Eye Institute2009–2011
- The Steroids For Cornea Ulcers TrialNational Eye Institute2005–2009
- Eliminating Trachoma With Repeat Mass Drug TreatmentNational Eye Institute2004–2009
- Predicting Resistance: Validating Mathematical ModelsNational Institute Of Allergy And Infectious Diseases2003–2004
- Transmission Dynamics Of TrachomaNational Institute Of Allergy And Infectious Diseases1997–2001
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
